Delivery Order SPE2DE24D0013-SPE2D626F97D5

The Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $4,320 to Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California, for delivery to the company's Sunnyvale facility. Awarded on January 9, 2026, with an ultimate completion date of January 16, 2026, this firm fixed-price delivery order carries no set-aside designation and represents a child contract under a larger indefinite delivery vehicle. Cepheid specializes in advanced molecular diagnostic solutions, particularly its GeneXpert diagnostic platform and associated reagents and test kits for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other pathogens.

As a primary federal supplier of diagnostic solutions, Cepheid has established an extensive portfolio of contracts across multiple defense and civilian healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company currently maintains significant indefinite delivery contracts with the VA, including a $32.8 million vehicle with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which generate ongoing delivery orders for diagnostic reagents and testing supplies to support clinical laboratory operations across the federal healthcare system. This particular $4,320 delivery order represents continued federal procurement of Cepheid's diagnostic capabilities through the DLA Medical Supply Chain's ordering mechanism.